Vor Biopharma Inc (VOR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Bob Ang
Employees:
140
215 FIRST STREET, SUITE 430, CAMBRIDGE, MA 02142
617-655-6580

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 386.019 Million Shares Outstanding65.649 Million Avg 30-day Volume 166.606 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.63
Price to Revenue0.0 Debt to Equity0.0 EBITDA-84.711 Million
Price to Book Value0.953 Operating Margin0.0 Enterprise Value15.209 Million
Current Ratio12.856 EPS Growth0.959 Quick Ratio12.256
1 Yr BETA 1.1311 52-week High/Low 7.57 / 3.48 Profit Margin0.0
Operating Cash Flow Growth-29.4427 Altman Z-Score-0.0658 Free Cash Flow to Firm -76.577 Million

View recent insider trading info

Vor Biopharma Inc YCharts
Yahoo! Finance finviz

Funds Holding VOR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VOR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANG ROBERT PRESIDENT AND CEO

  • Officer
  • Director
 700,665 2023-03-01 3

CHAKRABORTY TIRTHA CHIEF SCIENTIFIC OFFICER

  • Officer
 142,154 2023-03-01 3

JORGENSEN NATHAN D. CHIEF FINANCIAL OFFICER

  • Officer
 154,459 2023-03-01 3

ATTAR EYAL C. CHIEF MEDICAL OFFICER

  • Officer
 54,500 2023-02-06 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
 22,748,880 2022-12-09 2

PATTERSON MATTHEW R

  • Director
 16,911 2022-06-14 1

BECKMAN DANIELLA

  • Director
 16,911 2022-06-14 1

LUBNER DAVID CHARLES

  • Director
 16,911 2022-06-14 1

PARMAR KUSH

  • Director
  • 10% Owner
 16,911 2022-06-14 1

LUNDBERG SVEN ANTE

  • Director
 16,911 2022-06-14 1

RESNICK JOSHUA

  • Director
 16,911 2022-06-14 1

SLAPAK CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
 116,000 2022-02-01 0

5AM VENTURES VI, L.P.

5AM PARTNERS VI, LLC

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

SCHWAB ANDREW J.

  • 10% Owner
 6,361,723 2021-11-16 0

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
 No longer subject to file 2021-02-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

JORGENSEN NATHAN D. - Officer CHIEF FINANCIAL OFFICER

2023-03-02 18:35:49 -0500 2023-03-01 F 6,310 $5.51 d 154,459 direct 0.0 -10.5163 4.2065 3 -10.5163 6

CHAKRABORTY TIRTHA - Officer CHIEF SCIENTIFIC OFFICER

2023-03-02 18:37:48 -0500 2023-03-01 F 5,576 $5.51 d 142,154 direct 0.0 -10.5163 4.2065 3 -10.5163 6

ANG ROBERT - Director - Officer PRESIDENT AND CEO

2023-03-02 18:39:46 -0500 2023-03-01 F 12,657 $5.51 d 700,665 direct 0.0 -10.5163 4.2065 3 -10.5163 6

CHAKRABORTY TIRTHA - Officer CHIEF SCIENTIFIC OFFICER

2023-02-08 16:18:12 -0500 2023-02-06 A 47,750 a 147,730 direct 2.7829 -0.7421 9.0909 13.7291 10 -13.1725 21

CHAKRABORTY TIRTHA - Officer CHIEF SCIENTIFIC OFFICER

2023-02-08 16:18:12 -0500 2023-02-06 A 95,500 a 95,500 direct

ATTAR EYAL C. - Officer CHIEF MEDICAL OFFICER

2023-02-08 16:23:55 -0500 2023-02-06 A 54,500 a 54,500 direct 2.7829 -0.7421 9.0909 13.7291 10 -13.1725 21

ATTAR EYAL C. - Officer CHIEF MEDICAL OFFICER

2023-02-08 16:23:55 -0500 2023-02-06 A 109,000 a 109,000 direct

JORGENSEN NATHAN D. - Officer CHIEF FINANCIAL OFFICER

2023-02-08 16:22:04 -0500 2023-02-06 A 45,500 a 160,769 direct 2.7829 -0.7421 9.0909 13.7291 10 -13.1725 21

JORGENSEN NATHAN D. - Officer CHIEF FINANCIAL OFFICER

2023-02-08 16:22:04 -0500 2023-02-06 A 91,000 a 91,000 direct

ANG ROBERT - Director - Officer PRESIDENT AND CEO

2023-02-08 16:28:04 -0500 2023-02-06 A 128,750 a 713,322 direct 2.7829 -0.7421 9.0909 13.7291 10 -13.1725 21

ANG ROBERT - Director - Officer PRESIDENT AND CEO

2023-02-08 16:28:04 -0500 2023-02-06 A 257,500 a 257,500 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VOR BIOPHARMA INC VOR 2023-03-24 22:15:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 21:45:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 21:15:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 20:45:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 20:15:04 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 19:45:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 19:15:04 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 18:45:04 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 18:15:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 17:45:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 17:15:03 UTC 2.0349 2.7851 100000
VOR BIOPHARMA INC VOR 2023-03-24 16:45:03 UTC 2.0383 2.7817 100000
VOR BIOPHARMA INC VOR 2023-03-24 16:15:03 UTC 2.0383 2.7817 100000
VOR BIOPHARMA INC VOR 2023-03-24 15:45:03 UTC 2.0383 2.7817 100000
VOR BIOPHARMA INC VOR 2023-03-24 15:15:03 UTC 2.0383 2.7817 100000
VOR BIOPHARMA INC VOR 2023-03-24 14:45:03 UTC 2.0383 2.7817 100000
VOR BIOPHARMA INC VOR 2023-03-24 14:15:03 UTC 2.0383 2.7817 80000
VOR BIOPHARMA INC VOR 2023-03-24 13:45:03 UTC 2.092 2.478 80000
VOR BIOPHARMA INC VOR 2023-03-24 13:15:04 UTC 2.092 2.478 65000
VOR BIOPHARMA INC VOR 2023-03-24 12:45:03 UTC 2.092 2.478 60000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VOR -1300.0 shares, $-8645.0 2022-12-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VOR -964.0 shares, $-6410.6 2022-12-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments